Ecraid Foundation Science Meeting

Join the Ecraid Foundation Science Meeting, an academic event designed to engage with Europe’s first dedicated clinical research network for infectious diseases. This two-day meeting brings together infectious disease experts from academia, private, and public sectors to foster collaboration.

This edition follows a successful meeting in 2025 and will provide you with the opportunity to:

• Engage with opinion leaders in the field of infectious diseases
• Attend presentations from top experts
• Connect with the Ecraid team on ongoing or new potential projects
• Meet other stakeholders across the Ecraid network and learn from their experiences and services

Accreditation for the Scientific Programme has been requested from ABIC and NVNM for healthcare professionals holding a Dutch BIG registration. We will update the event page once accreditation has been granted.

Ecraid is a not-for-profit foundation, ticket sales cover the administrative costs of this academic event.

The agenda and key topics are outlined below. Exact times and more information will be provided on this page as they become availabile.

--------------------------------------------------------------------------------------------------

Participant learning outcomes:

1. Evaluate and debate adaptive trial methodologies. Participants will be able to critically evaluate the design, benefits, and challenges of adaptive platform trials (e.g., ECRAID-Prime, SNAP, TREAT-GNB, REMAP-CAP) and discuss their role in accelerating the discovery of effective therapeutics for severe bacterial and respiratory infections
2. Appraise the role of Perpetual Observational Studies (POS) in preparedness. Attendees will gain an understanding of how Ecraid's POS in both acute and primary care (ARI, cUTI, VAP) generate crucial, real-time participant-level data, and how this data informs clinical strategies and future ARI preparedness across Europe.
3. Translate data-driven epidemiology into policy action. Participants will learn practical applications for leveraging large-scale epidemiological tools, such as EPI-Net and the Emerging Resistance Index (ERI), to support evidence-based antibiotic policy and enhance infectious disease preparedness efforts.
4. Identify critical evidence gaps in ICU and primary care settings. Attendees will be able to identify and debate the current key clinical research gaps in high-acuity settings (e.g., needed steroid and antifungal trials in the ICU) and understand strategies for integrating complex clinical trials into the primary care setting.
5. Synthesise strategies for combating AMR and sepsis. Participants will synthesise high-level strategic insights regarding the prediction of sepsis outcomes and the use of antimicrobial resistance and antibiotic-use surveillance data to inform coordinated public health policies across Europe.